查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439284

經導管栓塞和封堵裝置 - 全球市場回顧、競爭格局、市場預測（2030 年）

Transcatheter Embolization And Occlusion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計2023年全球經導管栓塞和封堵器市場規模將達到40.4億美元，到2030年將達到68.4億美元，預計2024-2030年期間複合年增長率為9.14%。經導管栓塞和封堵器需求的主要驅動力是技術進步、心血管疾病、呼吸系統疾病和癌症等慢性疾病的擴散、高度結構化的醫療行業以及微創手術的採用。在老年人口等。

經導管栓塞和封堵器的市場動態

由於全球癌症和心血管疾病等慢性病負擔日益增加，經導管栓塞和封堵器械市場正經歷顯著成長。例如，根據世界衛生組織（WHO）（2022）的數據，2020年乳癌病例為226萬例，肺癌病例為221萬例，大腸癌病例為193萬例，攝護腺癌病例為141萬例，據報道，胃癌109萬例。

根據GLOBOCAN數據，2020年全球報告約1,930萬新發癌症病例，預計2040年這一數字將增加至3,020萬人。

此外，根據英國心臟基金會（2022）提供的數據，2019年全球約有5.5億人，即每14人中就有1人患有心臟和循環系統疾病，其中包括約2.9億女性和約2.6億男性。

隨著經導管栓塞和封堵器廣泛應用於治療各種慢性病患者，慢性病病例的快速增加推動了全球經導管栓塞和封堵器市場的成長。

此外，作為開放手術的替代方案，這些設備的採用正在增加，因為它們能夠最大限度地減少組織疼痛並減小切口尺寸，從而推動全球經導管栓塞和封堵設備市場的發展。這很有可能。

此外，大多數診斷實驗室和醫院都配備了新技術和良好的基礎設施。其主要目的是提高訪問率、準確性並降低成本。

產品成本高、對熟練醫生的需求以及產品商業化嚴格監管體係等某些因素可能會阻礙經導管栓塞和封堵裝置市場的成長。

經導管栓塞及封堵器市場區隔分析

在經導管栓塞和封堵器市場的類型細分中，在彈簧圈類別中，預計到2022年，可推式彈簧圈將佔據全球經導管栓塞和封堵器市場的大部分。該產品領域的快速成長歸功於這些設備的優勢和應用。

可推動的線圈用於機械閉塞外周和內臟血管。它具有成本效益、易於獲取且相對易於操作。

可推動的彈簧圈有多種應用，包括控制出血、閉塞動脈瘤、靜脈曲張和動靜脈瘺管等血管病變，以及血流重新分配以保護非目標血管。

例如，Terumo Corporation的AZUR TM Peripheral Hydrocoil-Pushable Peripheral Coil System用於降低或阻斷週邊血管中的血流速度。本設備適用於動靜脈畸形、動靜脈瘺管、動脈瘤和周邊脈管系統等病變的介入性放射治療。

此外，有利的報銷方案、這些設備的日益普及，以及印度、中國和巴西等發展中國家農村地區設備齊全的新建和現有醫院和醫療中心的優良醫療基礎設施，使得該設備的未來有望增加市場前景。

因此，所有上述因素預計將推動經導管栓塞和封堵器市場的成長。

本報告提供了全球經導管栓塞和封堵器材市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第一章經導管栓塞及封堵器材市場報告簡介

第二章經導管栓塞及閉塞器材市場的執行摘要

  • 調查範圍
  • 市場概況
  • 競爭評估

第三章 監管分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第四章經導管栓塞及封堵器市場關鍵因素分析

  • 經導管栓塞和封堵器市場的驅動因素
    • 慢性病盛行率增加
    • 先進技術整合
    • 增加來自投資以及公共和私人組織的資金
    • 老年人口增加
  • 經導管栓塞和封堵器市場的限制與挑戰
    • 設備成本高
    • 需要熟練的醫生
  • 經導管栓塞及閉塞器材市場的機會
    • 對微創設備的偏好
    • 新興國家的增長機會

第五章 經導管栓塞與封堵器的波特五力分析

第六章 經導管栓塞及封堵器市場佈局

  • 按類型
    • 線圈
    • 非盤繞的
  • 按用途
    • 週邊血管疾病
    • 瘤
    • 神經
    • 泌尿系統
    • 其他
  • 按最終用戶
    • 醫院
    • 門診手術中心
    • 診所
  • 按地區
    • 北美經導管栓塞和封堵器市場規模（2021-2030）
    • 歐洲經導管栓塞及封堵器市場規模（2021-2030）
    • 亞太地區經導管栓塞及封堵器市場規模（2021-2030）
    • 其他地區經導管栓塞及封堵器市場規模（2021-2030年）

第七章 經導管栓塞及封堵器公司及產品簡介

  • Boston Scientific Corporation
  • Medtronic PLC
  • Penumbra, Inc.
  • Cook Medical Inc.
  • Edwards Lifesciences Corporation
  • Merit Medical Systems, Inc.
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Kaneka Medix Corporation
  • Stryker Corporation
  • phenox GmbH
  • Braile Biomedica
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • W. L. Gore & Associates, Inc.

第8章 KOL觀點

第9章 專案方法

第10章 DelveInsight服務內容

第 11 章關於 DelveInsight

第十二章 免責聲明與聯絡我們

Product Code: DIMDCL0074

Transcatheter Embolization and Occlusion Devices Market By Type (Coiled [Pushable Coils and Detachable Coils], and Non-Coiled [Flow Diverting Devices, Embolization Particles, Liquid Embolic, and Others]), Application (Peripheral Vascular Disease, Oncology, Neurology, Urology, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Clinics), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to rising technological advancement and increasing prevalence of chronic diseases

The global transcatheter embolization and occlusion devices market was valued at USD 4.04 billion in 2023, growing at a CAGR of 9.14% during the forecast period from 2024 to 2030, to reach USD 6.84 billion by 2030. The demand for transcatheter embolization and occlusion devices is primarily attributed to the rising technological advancement, surge in the prevalence of chronic diseases like cardiovascular diseases, respiratory disorders, and cancer, highly structured healthcare industry, increased adoption of minimally invasive surgeries, and increasing geriatric population.

Transcatheter Embolization and Occlusion Devices Market Dynamics:

Transcatheter Embolization and Occlusion Devices Market has significantly increased due to the growing burden of chronic diseases such as cancer, cardiovascular, and others throughout the world. For instance, according to the data cited by the World Health Organization (WHO) 2022, worldwide around 2.26 million cases of breast, 2.21 million cases of lung, 1.93 million cases of colon and rectum, 1.41 million cases of prostate, and 1.09 million cases of stomach cancer were reported in 2020.

As per the GLOBOCAN data, around 19.3 million new cancer cases were reported around the world in 2020, and this number is expected to increase to 30.2 million people by 2040.

Also, the data provided by British Heart Foundation 2022 mentions that worldwide around 550 million which stands for 1 in 14 people were living with heart and circulatory diseases in 2019 and this includes about 290 million women and around 260 million men.

Transcatheter embolization and occlusion devices are largely employed in the treatment of patients suffering from various chronic diseases and thus, the burgeoning cases of chronic diseases will contribute to the global transcatheter embolization and occlusion devices market growth.

In addition, increased adoption of these devices as they are used in treatment as an alternative to open surgery with minimum tissue pain and smaller incisions is likely to boost the global transcatheter embolization and occlusion devices market.

Moreover, most diagnostic labs and hospitals are equipped with new techniques and better infrastructure facilities. The predominant goal is to improve access and precision, and decrease cost.

Certain factors such as the high cost of products, the requirement of skilled physicians, and the existence of a rigid regulatory system for product commercialization would hinder the growth of the transcatheter embolization and occlusion devices market.

Transcatheter Embolization and Occlusion Devices Market Segment Analysis:

Transcatheter Embolization and Occlusion Devices by Type (Coiled [Pushable Coils and Detachable Coils], and Non-Coiled [Flow Diverting Devices, Embolization Particles, Liquid Embolic, and Others]), Application (Peripheral Vascular Disease, Oncology, Neurology, Urology, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Clinics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Transcatheter Embolization and Occlusion Devices market type segment, under the coiled category, the pushable coils are expected to hold the majority of the global transcatheter embolization and occlusion devices market in 2022. The rapid growth of this product segment can be attributed to the advantages and applications of these devices.

Pushable coils are utilized for mechanical occlusion of peripheral and visceral vessels. These are cost-effective, easily accessible, and comparatively easier to handle.

Pushable coils have various applications and these are intended for bleeding control, to occlude vascular lesions such as aneurysms, varices, and arteriovenous fistulas (AVFs), and for redistributing the blood flow to protect nontarget vessels among others.

For example, AZUR(TM) Peripheral Hydrocoil - Pushable Peripheral Coil System by Terumo Corporation is meant for reducing or blocking the rate of blood flow in vessels of the peripheral vasculature. The device is indicated for use in the interventional radiologic management of arteriovenous malformations, arteriovenous fistulae, aneurysms, and other lesions of the peripheral vasculature.

Additionally, favorable reimbursement scenarios, increasing adoption of these devices, and better healthcare infrastructure with equipped new/existing hospitals and healthcare centers in rural regions of developing countries such as India, China, Brazil, and others are expected to enhance the market potential of this equipment.

Hence, all the above-mentioned factors are expected to drive the segment growth of the transcatheter embolization and occlusion devices market.

North America is expected to dominate the Overall Transcatheter Embolization and Occlusion Devices Market:

North America is expected to dominate the overall transcatheter embolization and occlusion devices market during the forecast period. This domination is due to the rising prevalence of various chronic diseases such as cancer, cardiovascular diseases, and others coupled with improved reimbursement policies, easy accessibility, and high adoption of technological advancements owing to the rise in healthcare expenditure by the US government. Further, the United States represents the largest market worldwide supported by developed healthcare infrastructure.

The Centers for Disease Control and Prevention (CDC) 2022, estimated that about 20.1 million adults aged 20 and older had Coronary artery disease (CAD) in the US, in 2020.

The source mentioned above stated that in the United States, someone has a heart attack every 40 seconds. Every year, about 805,000 people in the United States have a heart attack. Out of these, 605,000 are a first heart attack, 200,000 happen to people who have already had a heart attack and about 1 in 5 heart attacks are silent-the damage is done, but the person is not aware of it.

The increasing number of product development activities in the region is further going to accelerate the growth transcatheter embolization and occlusion devices market. For example, in March 2022, Artio Medical, Inc. received the US Food and Drug Administration (FDA) clearance for its Solus Gold Embolization Device, a next-generation product for peripheral vascular occlusion.

Thus, the factors mentioned above are going to positively drive the North America transcatheter embolization and occlusion devices market forward during the forecast period.

Transcatheter Embolization and Occlusion Devices Market Key Players:

Some of the key market players operating in the transcatheter embolization and occlusion devices market include Boston Scientific Corporation, Medtronic PLC, Penumbra, Inc., Cook Medical Inc., Edwards Lifesciences Corporation, Merit Medical Systems, Inc., Johnson & Johnson Services, Inc., Lepu Medical Technology(Beijing)Co., Ltd., Kaneka Medix Corporation, Stryker Corporation, phenox GmbH, Braile Biomedica, Terumo Corporation, MicroPort Scientific Corporation, W. L. Gore & Associates, Inc., and others.

Recent Developmental Activities in the Transcatheter Embolization and Occlusion Devices Market:

In April 2022, Medtronic plc announced it has received approval from the United States Food and Drug Administration (FDA) for Pipeline(TM) Flex Embolization Device with Shield Technology(TM). Medtronic developed Shield Technology, a proprietary breakthrough in biomaterial science, to advance flow diversion therapy by introducing the first surface-modified implant device which demonstrates the reduction in material thrombogenicity, a reduction in the tendency of the surface treatment material to create clots.

In March 2022, The US Food and Drug Administration (FDA) cleared Boston Scientific's TheraSphere Y-90 Glass Microspheres, an interventional radiology therapy developed for the transcatheter treatment of patients with hepatocellular carcinoma (HCC).

In August 2020, Stryker announced that it has received US Food and Drug Administration (FDA) approval for an expanded indication of its Neuroform Atlas Stent System, becoming the first and only adjunctive stent approved for use in the posterior (back of the brain) circulation. The Neuroform Atlas Stent System is indicated for use with neurovascular embolization coils in the anterior and posterior circulation of the neurovasculature for endovascular treatment.

Key Takeaways from the Transcatheter Embolization and Occlusion Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Transcatheter Embolization and Occlusion Devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global transcatheter embolization and occlusion devices market.

Various opportunities are available for the other competitor in the transcatheter embolization and occlusion devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for transcatheter embolization and occlusion devices market growth in the coming future?

Target Audience who can be benefited from this transcatheter embolization and occlusion devices market ket report study

Transcatheter Embolization and Occlusion Devices providers

Research organizations and consulting companies

Transcatheter Embolization and Occlusion Devices related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in transcatheter embolization and occlusion devices

Various End-Users want to know more about the transcatheter embolization and occlusion devices market and the latest technological developments in the transcatheter embolization and occlusion devices market.

Frequently Asked Questions for Transcatheter Embolization and Occlusion Devices Market:

1. What are Transcatheter Embolization and Occlusion Devices?

In interventional radiology, transcatheter embolization and occlusion (TEO) is a minimally invasive (MI) treatment in which a synthetic embolus is positioned or implanted into the blood vessel via a fine catheter to block the flow of blood to the tumor or other areas of the body.

2. What is the market for global transcatheter embolization and occlusion devices?

The global transcatheter embolization and occlusion devices market was valued at USD 4.04 billion in 2023, growing at a CAGR of 9.14% during the forecast period from 2024 to 2030, to reach USD 6.84 billion by 2030.

3. What are the drivers for the global transcatheter embolization and occlusion devices market?

The major drivers driving the demand for transcatheter embolization and occlusion devices are rising technological advancement, a surge in the incidence of cardiovascular diseases, respiratory disorders, and cancer, a highly structured healthcare industry, increased adoption of minimally invasive surgeries, and an increasing geriatric population among others.

4. Who are the key players operating in global transcatheter embolization and occlusion devices?

Some of the key market players operating in the transcatheter embolization and occlusion devices market include Boston Scientific Corporation, Medtronic PLC, Penumbra, Inc., Cook Medical Inc., Edwards Lifesciences Corporation, Merit Medical Systems, Inc., Johnson & Johnson Services, Inc., Lepu Medical Technology(Beijing)Co., Ltd., Kaneka Medix Corporation, Stryker Corporation, phenox GmbH, Braile Biomedica, Terumo Corporation, MicroPort Scientific Corporation, W. L. Gore & Associates, Inc., and others.

5. Which region has the highest share in the transcatheter embolization and occlusion devices market?

North America is expected to dominate the overall transcatheter embolization and occlusion devices market during the forecast period, 2024 to 2030. This domination is due to the improved reimbursement policies, easy accessibility, and high adoption of technological advancements owing to the rise in healthcare expenditure by the US government.

Table of Contents

1. Transcatheter Embolization and Occlusion Devices Market Report Introduction

2. Transcatheter Embolization and Occlusion Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Transcatheter Embolization and Occlusion Devices Market Key Factors Analysis

  • 4.1. Transcatheter Embolization and Occlusion Devices Market Drivers
    • 4.1.1. Increasing incidence of chronic diseases
    • 4.1.2. Integration of advanced technology
    • 4.1.3. The rise in the investments, and funds by public-private organizations
    • 4.1.4. Increasing geriatric population
  • 4.2. Transcatheter Embolization and Occlusion Devices Market Restraints and Challenges
    • 4.2.1. High cost of the devices
    • 4.2.2. Requirement of skilled physicians
  • 4.3. Transcatheter Embolization and Occlusion Devices Market Opportunities
    • 4.3.1. Preference for minimally invasive devices
    • 4.3.2. Growth opportunities in emerging countries

5. Transcatheter Embolization and Occlusion Devices Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Transcatheter Embolization and Occlusion Devices Market layout

  • 6.1. By Type
    • 6.1.1. Coiled
      • 6.1.1.1. Pushable Coils
      • 6.1.1.2. Detachable Coils
    • 6.1.2. Non-Coiled
      • 6.1.2.1. Flow Diverting Devices
      • 6.1.2.2. Embolization Particles
      • 6.1.2.3. Liquid Embolic
      • 6.1.2.4. Others
  • 6.2. By Application
    • 6.2.1. Peripheral Vascular Disease
    • 6.2.2. Oncology
    • 6.2.3. Neurology
    • 6.2.4. Urology
    • 6.2.5. Others
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Ambulatory Surgical Centers
    • 6.3.3. Clinics
  • 6.4. By Geography
    • 6.4.1. North America Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.1.1. United States Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.2. Europe Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.1. France Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.1. China Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.3. India Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of Asia-Pacific Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW) Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.4.1. Middle East Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)

7. Transcatheter Embolization and Occlusion Devices Company and Product Profiles

  • 7.1. Boston Scientific Corporation
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Medtronic PLC
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Penumbra, Inc.
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Cook Medical Inc.
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Edwards Lifesciences Corporation
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Merit Medical Systems, Inc.
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Johnson & Johnson Services, Inc.
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Lepu Medical Technology(Beijing)Co., Ltd.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Kaneka Medix Corporation
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Stryker Corporation
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. phenox GmbH
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Braile Biomedica
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Terumo Corporation
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. MicroPort Scientific Corporation
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. W. L. Gore & Associates, Inc.
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Transcatheter Embolization and Occlusion Devices Market in Global (2021-2030)
  • Table 3: Transcatheter Embolization and Occlusion Devices Market in Global by Type (2021-2030)
  • Table 4: Transcatheter Embolization and Occlusion Devices Market in Global by Application (2021-2030)
  • Table 5: Transcatheter Embolization and Occlusion Devices Market in Global by End-User (2021-2030)
  • Table 6: Transcatheter Embolization and Occlusion Devices Market in Global by Geography (2021-2030)
  • Table 7: Transcatheter Embolization and Occlusion Devices Market in North America (2021-2030)
  • Table 8: Transcatheter Embolization and Occlusion Devices Market in the US (2021-2030)
  • Table 9: Transcatheter Embolization and Occlusion Devices Market in Canada (2021-2030)
  • Table 10: Transcatheter Embolization and Occlusion Devices Market in Mexico (2021-2030)
  • Table 11: Transcatheter Embolization and Occlusion Devices Market in Europe (2021-2030)
  • Table 12: Transcatheter Embolization and Occlusion Devices Market in France (2021-2030)
  • Table 13: Transcatheter Embolization and Occlusion Devices Market in Germany (2021-2030)
  • Table 14: Transcatheter Embolization and Occlusion Devices Market in the United Kingdom (2021-2030)
  • Table 15: Transcatheter Embolization and Occlusion Devices Market in Italy (2021-2030)
  • Table 16: Transcatheter Embolization and Occlusion Devices Market in Spain (2021-2030)
  • Table 17: Transcatheter Embolization and Occlusion Devices Market in Rest of Europe (2021-2030)
  • Table 18: Transcatheter Embolization and Occlusion Devices Market in Asia-Pacific (2021-2030)
  • Table 19: Transcatheter Embolization and Occlusion Devices Market in China (2021-2030)
  • Table 20: Transcatheter Embolization and Occlusion Devices Market in Japan (2021-2030)
  • Table 21: Transcatheter Embolization and Occlusion Devices Market in India (2021-2030)
  • Table 22: Transcatheter Embolization and Occlusion Devices Market in Australia (2021-2030)
  • Table 23: Transcatheter Embolization and Occlusion Devices Market in South Korea (2021-2030)
  • Table 24: Transcatheter Embolization and Occlusion Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Transcatheter Embolization and Occlusion Devices Market Analysis in the Rest of the World (2021-2030)
  • Table 26: Transcatheter Embolization and Occlusion Devices Market in the Middle East (2021-2030)
  • Table 27: Transcatheter Embolization and Occlusion Devices Market in Africa (2021-2030)
  • Table 28: Transcatheter Embolization and Occlusion Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Transcatheter Embolization and Occlusion Devices Market in Global (2021-2030)
  • Figure 3: Transcatheter Embolization and Occlusion Devices Market in Global by Type (2021-2030)
  • Figure 4: Transcatheter Embolization and Occlusion Devices Market in Global by Application (2021-2030)
  • Figure 5: Transcatheter Embolization and Occlusion Devices Market in Global by End-User (2021-2030)
  • Figure 6: Transcatheter Embolization and Occlusion Devices Market in Global by Geography (2021-2030)
  • Figure 7: Transcatheter Embolization and Occlusion Devices Market in North America (2021-2030)
  • Figure 8: Transcatheter Embolization and Occlusion Devices Market in the US (2021-2030)
  • Figure 9: Transcatheter Embolization and Occlusion Devices Market in Canada (2021-2030)
  • Figure 10: Transcatheter Embolization and Occlusion Devices Market in Mexico (2021-2030)
  • Figure 11: Transcatheter Embolization and Occlusion Devices Market in Europe (2021-2030)
  • Figure 12: Transcatheter Embolization and Occlusion Devices Market in France (2021-2030)
  • Figure 13: Transcatheter Embolization and Occlusion Devices Market in Germany (2021-2030)
  • Figure 14: Transcatheter Embolization and Occlusion Devices Market in the United Kingdom (2021-2030)
  • Figure 15: Transcatheter Embolization and Occlusion Devices Market in Italy (2021-2030)
  • Figure 16: Transcatheter Embolization and Occlusion Devices Market in Spain (2021-2030)
  • Figure 17: Transcatheter Embolization and Occlusion Devices Market in Rest of Europe (2021-2030)
  • Figure 18: Transcatheter Embolization and Occlusion Devices Market in Asia-Pacific (2021-2030)
  • Figure 19: Transcatheter Embolization and Occlusion Devices Market in China (2021-2030)
  • Figure 20: Transcatheter Embolization and Occlusion Devices Market in Japan (2021-2030)
  • Figure 21: Transcatheter Embolization and Occlusion Devices Market in India (2021-2030)
  • Figure 22: Transcatheter Embolization and Occlusion Devices Market in Australia (2021-2030)
  • Figure 23: Transcatheter Embolization and Occlusion Devices Market in South Korea (2021-2030)
  • Figure 24: Transcatheter Embolization and Occlusion Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Transcatheter Embolization and Occlusion Devices Market in the Rest of the World (2021-2030)
  • Figure 26: Transcatheter Embolization and Occlusion Devices Market in the Middle East (2021-2030)
  • Figure 27: Transcatheter Embolization and Occlusion Devices Market in Africa (2021-2030)
  • Figure 28: Transcatheter Embolization and Occlusion Devices Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Market Opportunities
  • Figure 32: PORTER'S Five Force Analysis